Weill Medical College of Cornell University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Weill Medical College of Cornell University sits in the top decile of US sponsors by registered trial count (#49 of 15,742 sponsors by registered trial count).
Weill Medical College of Cornell University: 701 sponsored US clinical trials, 127 recruiting.
Weill Medical College of Cornell University sponsors 701 registered US clinical trials on ClinicalTrials.gov, 127 of them currently recruiting, and 387 completed. 89 of these trials are in Phase 3-4 (later-stage) and 197 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Prostate Cancer, with 20 trials.
Top-decile sponsor footprint
Weill Medical College of Cornell University ranks in the top decile of sponsors by registered trial count (#49 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
387 of 515 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (75.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
701 total, page 10 of 15
Analysis of Stroke Rehabilitation Outcomes
NCT02876783
Incident COronary EveNts Identified by Computed Tomography
NCT02959099
Emotional and Cognitive Control in Late-Onset Depression
NCT01728194
Comparing Paper-based and Tablet-delivered Informed Consent for Older Adults
NCT02114970
Thalidomide, Lenalidomide, and Rituximab for Previously Treated Waldenstrom Macroglobulinemia
NCT01779167
Outcome Analysis for Minimally Invasive Spine Surgery and Navigation
NCT01751841
Seprafilm Slurry in the Prevention of Uterine Scarring in Patients Undergoing Hysteroscopic Myomectomy
NCT01632202
FemVue and Tubal Patency
NCT01880073
Intra-arterial Chemotherapy for Spinal Metastases
NCT01637766
Regulation of Stem Spermatogonia in the Mature Testis
NCT02756923
Intra-operative Use of Indigo Carmine Dye for the Delineation of Ill Defined Tumor Borders Using Stereotactic Injection
NCT01767415
Alternating Thalidomide and Lenalidomide Therapy Plus Rituximab (ThRiL) as Initial Treatment for Patients With CLL
NCT01125176
Ecosystem Focused Therapy in Post Stroke Depression
NCT01624402
Open Treatment of Minocycline in Geriatric Depression
NCT01659320
Psychotherapy for Late Life Depression
NCT01698255
Combined Amiodarone and Electrical Cardioversion for Postoperative Atrial Fibrillation After Cardiac Surgery
NCT01558128
In Vitro Maturation (IVM) of Human Oocytes
NCT01550861
Venous Sinus Stenting for Idiopathic Intracranial Hypertension Refractory to Medical Therapy
NCT01407809
N-Acetylcysteine for Neuroprotection in Parkinson's Disease
NCT01470027
Intra-arterial Thrombolysis for Severe Recent Central Retinal Vein Occlusion
NCT01581411
A Retrospective Chart Review of Thirty Three Children Who Have Received Clinical Treatment With Either Romiplostim or Eltrombopag From 2009-2013
NCT01974232
Collection of Cerebrospinal Fluid in Healthy Children
NCT01698229
Sustaining Remission of Psychotic Depression
NCT01427608
Differences in Efficacy Between Nasal and Oronasal Masks in the Treatment of OSA With CPAP
NCT01909674
Longitudinal Survey Analysis in Lymphoma Survivors
NCT01469754
Polar Body Biopsy for Preimplantation Genetic Screening
NCT01574404
Follicular Flushing
NCT01558141
Brain Dynamics in Different Stages of Arousal and Anesthesia
NCT01574443
Study of Biologic Materials From the Mediastinal Lymph Nodes From Patients With Lung Disease.
NCT02168036
Lenalidomide Plus Rituxan for Untreated Mantle Cell Lymphoma
NCT01472562
Fresolimumab and Radiotherapy in Metastatic Breast Cancer
NCT01401062
Decitabine and Plerixafor in Elderly Acute Myeloid Leukemia (AML)
NCT01352650
Epigenetic Priming Using Azacitidine With Neoadjuvant Chemotherapy for Resectable Esophageal Cancer
NCT01386346
Assessing the Impact of Health Information Exchange (HIE) on Healthcare Utilization
NCT01147328
End of EXTEND: Discontinuation of Medication for Patients With Immune Thrombocytopenia
NCT01386723
Study of the Impact of a Hospital Discharge Care Coordination Program in an Elderly Population
NCT01440907
Enhancing Exposure Therapy for Post Traumatic Stress Disorder (PTSD): Virtual Reality and Imaginal Exposure With a Cognitive Enhancer
NCT01352637
Phase I Clinical Trial to Evaluate the Safety, Pharmacokinetics and Efficacy of CW002
NCT01338935
Adapting Dialectical Behavior Therapy for Children in Residential Care
NCT01547052
Modulation of Genes Responsible for Cilia Length by Exposure to Cigarette Smoke
NCT02168673
Usage of Health Information Exchange (HIE) Technologies
NCT01250288
Home-delivered Intervention for Depressed, Cognitively Impaired Elders
NCT01350349
Trial of Three Stem Cell Mobilization Regimens for Multiple Myeloma
NCT01146834
Carboplatin and Paclitaxel in Patients With Metastatic, Castrate-Resistant Prostate Cancer
NCT01558492
Personalized Antidepressant Adherence Strategies For Depressed Elders
NCT01301859
Intervention for Anxiety After Falls
NCT01268657
Effectiveness of Celecoxib After Surgical Sperm Retrieval
NCT01323595
A Chart Review of Rituximab Plus Repeated Cycles of Dexamethasone
NCT02050581
Conventional Laparoscopic Versus Laparoendoscopic Single Site Donor Nephrectomy in Living Donor Kidney Transplantation
NCT01236326
Effect of Inhaled Steroids on Gene Expression in the Lungs - 2
NCT00826748
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 86 |
| Phase 2 | 111 |
| Phase 3 | 26 |
| Phase 4 | 63 |
Therapeutic Areas
What is open in the Weill Medical College of Cornell University pipeline
127 recruiting of 701 indexed (18% open); 387 completed (55%).
Phase mix: 89 late (III/IV) vs 197 early (I/II) (early-phase heavy).
Top condition: Prostate Cancer (20 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Weill Medical College of Cornell University: open-pipeline peers nationwide
Peers matched on 701 registered trials and 18% open enrollment, not the therapeutic-area sidebar.
Weill Medical College of Cornell University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 701 trials (± recruiting share)
- Icahn School of Medicine at Mount Sinai · 708 trials · 23% recruiting
- Sanofi · 713 trials · 10% recruiting
- The Cleveland Clinic · 688 trials · 14% recruiting
- University of Miami · 721 trials · 20% recruiting
Sponsors near 18% open enrollment (± trial volume)
- Children's Hospital of Philadelphia · 18% recruiting · 431 trials
- University of California, Berkeley · 18% recruiting · 72 trials
- Burke Medical Research Institute · 18% recruiting · 11 trials
- Grand Valley State University · 18% recruiting · 11 trials
Related
What to do with this Weill Medical College of Cornell University page
701 registered trials is a research-attention snapshot, not an endorsement of Weill Medical College of Cornell University or any single study.
- 127 of Weill Medical College of Cornell University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Prostate Cancer is the condition Weill Medical College of Cornell University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Prostate Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Weill Medical College of Cornell University pipeline card: 701 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.